Setback: Bharat Biotech Covaxin denied emergency use authorization in US Ruchika Sharma12 Jun 2021 11:45 AM ISTNew Delhi: In a setback to Bharat Biotech's COVID-19 vaccine Covaxin, the US Food and Drug Administration has "recommended" Ocugen Inc, the US partner...
Ocugen pays USD 15 million upfront to Bharat Biotech for Covaxin rights in Canada Ruchika Sharma8 Jun 2021 3:43 PM ISTNew Delhi: Ocugen Inc, the US partner for Bharat Biotech's Covid-19 vaccine, has announced the payment of USD 15 million upfront to the Indian drug...
Bharat Biotech - Ocugen agreement amended to expand Covaxin commercialization rights to include Canada Ruchika Sharma6 Jun 2021 10:00 AM ISTHyderabad: Bharat Biotech and Ocugen have announced that they have entered into an amendment to their Co-development, Supply, and...
Bharat biotech in talks with multinational pharma giants to boost COVAXIN production: Report Medical Dialogues Team3 May 2021 3:14 PM ISTHyderabad: With a motive to expand Covaxin production globally, Bharat Biotech is currently in talks with multinational pharma giants over producing...
Bharat Biotech pursues Covaxin nod in more than 40 countries Ruchika Sharma19 Feb 2021 11:51 AM ISTCOVAXIN is one of the two vaccines approved for emergency use in India, though efficacy data from its late-stage trial is yet to be published.
Bharat Biotech, Ocugen join hands for commercialization of Covaxin in US Ruchika Sharma3 Feb 2021 12:47 PM ISTMalvern & Hyderabad: Ocugen, Inc. and Bharat Biotech, today announced they have entered into a definitive agreement to co-develop, supply,...
